Recent studies suggest that TUDCA is effective in e.g., increasing insulin sensitivity [99], potentiating insulin clearance [107], and increasing pancreatic beta-cell mass [103] in obese humans and murine models of obesity and diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.